Search results
Jun 7, 2024 · Qu Biologics is currently enrolling patients with late-stage colorectal cancer undergoing surgical resection of liver metastases in a randomized, placebo-controlled Phase II multicenter trial to assess the effectiveness of QBECO SSI in reducing post-operative immune suppression and improving cancer outcomes. The engagement with Foundation ...
Jun 6, 2024 · Qu Biologics is currently enrolling patients with late-stage colorectal cancer undergoing surgical resection of liver metastases in a randomized, placebo-controlled Phase II multicenter trial (...
- Qu Biologics, Inc.
May 31, 2024 · The incidence of early onset colorectal cancer (EOCRC) in Canada has increased. To address the growing incidence of EOCRC, Colorectal Cancer Canada (CCC) developed the Never Too Young (N2Y) program to identify gaps in care and evaluate patient and caregiver experiences with CRC.
May 30, 2024 · Abstract: Despite ongoing screening eforts, colorectal cancer (CRC) remains a leading cause of death in Canada. The aim of this study was to beter understand the experiences of Canadian CRC patients with their family practitioners (FPs) during and after their CRC diagnosis.
Jun 20, 2024 · Determining the stage of colorectal cancer is important because it helps determine treatment options and, ultimately, the prognosis of the disease. This article will review the stages of colorectal cancer, how each stage is determined, and how this information can relate to survival outcomes.
Jun 6, 2024 · Researchers examined whether the PD-1 inhibitor pembrolizumab given neoadjuvantly may improve outcomes in certain patients with stage II or III mismatch repair–deficient/microsatellite instability–high colorectal cancer.
Jun 2, 2024 · In definitively unresectable colorectal cancer liver metastases (uCLM), palliative chemotherapy is the standard of care with almost no chance of long-term survival and cure.
